Literature DB >> 17570437

Intravesical prostatic protrusion is better than prostate volume in predicting the outcome of trial without catheter in white men presenting with acute urinary retention: a prospective clinical study.

Paramananthan Mariappan1, David J G Brown, Alan S McNeill.   

Abstract

PURPOSE: Trial without catheter after a short course of an alpha-blocker in men presenting with acute urinary retention is successful in up to 50% of cases. The ability to better predict outcome could avoid a trial without catheter for some men. Intravesical prostatic protrusion and not prostate volume has been shown to predict trial without catheter outcome in an Asian cohort. We investigated the relationship between the outcome of trial without catheter and prostate volume and intravesical prostatic protrusion in white men given alpha-blockers before a trial without catheter.
MATERIALS AND METHODS: Consecutive men 50 years old or older presenting with acute urinary retention were prospectively recruited based on strict selection criteria. At presentation factors thought to precipitate acute urinary retention were treated, alpha-blocker therapy started and the patient brought back for a trial without catheter after 2 weeks. Prostate volume and intravesical prostatic protrusion were measured by standard transrectal ultrasonography.
RESULTS: Of 121 men presenting with acute urinary retention 57 fulfilled the study selection criteria. Mean (+/- SD) age, prostate volume and intravesical prostatic protrusion of recruited men were 70 +/- 9.2 years, 69.7 +/- 36.3 ml and 12.8 +/- 10.1 mm, respectively. A total of 25 men (43.9%) had a successful trial without catheter. Mean intravesical prostatic protrusion was significantly smaller in those who had a successful trial without catheter (7.2 vs 16.5 mm, 95% CI 4.5-14, p <0.001). With intravesical prostatic protrusion correlating well with prostate volume (r = 0.588), mean prostate volume was also smaller in men with a successful trial without catheter, albeit with a smaller effect size. Men with an intravesical prostatic protrusion of 10 mm or less, compared to those with a larger intravesical prostatic protrusion, were 6 times more likely to have a successful trial without catheter.
CONCLUSIONS: In this cohort presenting with acute urinary retention related to benign prostatic hyperplasia and receiving alpha-blockers before a trial without catheter, intravesical prostatic protrusion appears to strongly predict the outcome of a trial without catheter. A trial without catheter is more likely to fail in patients with intravesical prostatic protrusion larger than 10 mm.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17570437     DOI: 10.1016/j.juro.2007.03.116

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  21 in total

1.  Ultrasound image features of intravesical prostatic protrusion indicated failure of medication therapy of finasteride and doxazosin in patients with benign prostatic hyperplasia (LUTS/BPH).

Authors:  Qiang Liu; Yunkai Zhu; Jianping Liu; Jun Qi; Jian Kang
Journal:  Int Urol Nephrol       Date:  2016-12-16       Impact factor: 2.370

2.  Intravesical prostatic protrusion in men in Olmsted County, Minnesota.

Authors:  Michael M Lieber; Debra J Jacobson; Michaela E McGree; Jennifer L St Sauver; Cynthia J Girman; Steven J Jacobsen
Journal:  J Urol       Date:  2009-10-17       Impact factor: 7.450

3.  Clinical and urodynamic significance of morphological differences in intravesical prostatic protrusion.

Authors:  Seung Wook Lee; Jeong Man Cho; Jung Yoon Kang; Tag Keun Yoo
Journal:  Korean J Urol       Date:  2010-10-21

Review 4.  Α₁-blockers in the management of acute urinary retention secondary to benign prostatic hyperplasia: a systematic review and meta-analysis.

Authors:  D Guang-Jun; G Feng-Bin; J Xun-Bo
Journal:  Ir J Med Sci       Date:  2014-03-06       Impact factor: 1.568

5.  Influence of intravesical prostatic protrusion on preoperative lower urinary tract symptoms and outcomes after 120 w high performance system laser treatment in men with benign prostatic hyperplasia.

Authors:  Jang Ho Wee; Yong Sun Choi; Woong Jin Bae; Su Jin Kim; Hyuk Jin Cho; Sung-Hoo Hong; Ji Youl Lee; Sae Woong Kim
Journal:  Korean J Urol       Date:  2012-07-19

6.  Predicting outcome of trial of voiding without catheter in acute urinary retention with intravesical prostatic protrusion.

Authors:  Osman Syazarina Sharis; Md Zainuddin Zulkifli; Abdul Hamid Hamzaini
Journal:  Malays J Med Sci       Date:  2013-01

7.  Impact of the presence of a median lobe on functional outcomes of greenlight photovaporization of the prostate (PVP): an analysis of the Global Greenlight Group (GGG) Database.

Authors:  David-Dan Nguyen; Iman Sadri; Kyle Law; Naeem Bhojani; Dean S Elterman; Ahmed S Zakaria; Adel Arezki; Franck Bruyère; Luca Cindolo; Giovanni Ferrari; Carlos Vasquez-Lastra; Tiago Borelli-Bovo; Edgardo F Becher; Hannes Cash; Maximillian Reimann; Enrique Rijo; Vincent Misrai; Kevin C Zorn
Journal:  World J Urol       Date:  2021-01-03       Impact factor: 4.226

8.  Does the combination of intravesical prostatic protrusion and bladder outlet obstruction number increase test accuracy according to benign prostatic obstruction at the individual level?

Authors:  Damir Aganovic; Alden Prcic; Osman Hadziosmanovic; Munira Hasanbegovic
Journal:  Acta Inform Med       Date:  2012-09

9.  Effect of photoselective vaporization prostatectomy on lower urinary tract symptoms in benign prostatic hyperplasia with or without intravesical prostatic protrusion.

Authors:  Myung Soo Kim; Kyung Kgi Park; Byung Ha Chung; Seung Hwan Lee
Journal:  Korean J Urol       Date:  2013-01-18

Review 10.  Clinical Considerations for Intravesical Prostatic Protrusion in the Evaluation and Management of Bladder Outlet Obstruction Secondary to Benign Prostatic Hyperplasia.

Authors:  Jason Gandhi; Steven J Weissbart; Albert N Kim; Gunjan Joshi; Steven A Kaplan; Sardar Ali Khan
Journal:  Curr Urol       Date:  2018-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.